Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00040937 · FLOW

Participant flow

S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma · Source last updated 2016-12-08

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    thalidomide/dexamethasone followed by tandem melphalan peripheral blood stem cell transplantation (with cyclophosphamide and filgrastim or sargramostim support) and prednisone/thalidomide maintenance
    id
    FG000
    title
    Treatment Arm
periods
  1. milestones
    1. achievements
      1. comment
        147 registered to this period; 142 were eligible and analyzable; 140 were assessable for toxicity.
        group Id
        FG000
        num Subjects
        147
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        110
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        37
      type
      NOT COMPLETED
    title
    Induction/PBSC Mobilization
  2. milestones
    1. achievements
      1. comment
        108 registered to this period; 105 were eligible and analyzable; 105 were assessable for toxicity.
        group Id
        FG000
        num Subjects
        108
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        77
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        31
      type
      NOT COMPLETED
    title
    Autologous PBSCT
  3. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        76
      type
      STARTED
    2. achievements
      1. comment
        Patients remained on protocol therapy until progression.
        group Id
        FG000
        num Subjects
        76
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Maintenance
recruitment Details
Patients were recruited at participating cooperative group institutions.
Complete source fields
groups
  1. description
    thalidomide/dexamethasone followed by tandem melphalan peripheral blood stem cell transplantation (with cyclophosphamide and filgrastim or sargramostim support) and prednisone/thalidomide maintenance
    id
    FG000
    title
    Treatment Arm
periods
  1. milestones
    1. achievements
      1. comment
        147 registered to this period; 142 were eligible and analyzable; 140 were assessable for toxicity.
        group Id
        FG000
        num Subjects
        147
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        110
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        37
      type
      NOT COMPLETED
    title
    Induction/PBSC Mobilization
  2. milestones
    1. achievements
      1. comment
        108 registered to this period; 105 were eligible and analyzable; 105 were assessable for toxicity.
        group Id
        FG000
        num Subjects
        108
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        77
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        31
      type
      NOT COMPLETED
    title
    Autologous PBSCT
  3. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        76
      type
      STARTED
    2. achievements
      1. comment
        Patients remained on protocol therapy until progression.
        group Id
        FG000
        num Subjects
        76
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Maintenance
recruitment Details
Patients were recruited at participating cooperative group institutions.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice